GlaxoSmithkline in pink of health
Economic Times, India
GlaxoSmithkline pharma (GSK) reported 8.1% yoy growth in its net sales to Rs 375 crore in the quarter ended December ‘08, which was lower than the 15% yoy growth reported in its core pharma business in the September ‘08 quarter.
MNCs ahead of Indian cos in dividend race Economic Times
all 2 news articles